Article

Silent familial isolated pituitary adenomas: histopathological and clinical case report.

Department of Human and Hereditary Pathology, S. Matteo IRCCS Foundation, University of Pavia, Pavia, Italy.
Endocrine Pathology (Impact Factor: 1.6). 04/2008; 19(1):40-6. DOI:10.1007/s12022-008-9018-2
Source: PubMed

ABSTRACT Familial isolated pituitary adenoma (FIPA) is a rare condition independent of Carney Complex or MEN1. An international multicenter study recently described 28 nonfunctioning pituitary adenomas in 26 families with only two homogeneous nonsecreting phenotype families consistent of silent GH and silent gonadotroph adenomas, respectively. We present the clinical, genetic, and morphological analysis of two silent pituitary adenomas occurring in a man and his daughter, and discuss the differential diagnosis associated with their histological, immunohistochemical, and ultrastructural features. The patients developed invasive nonsecreting macroadenomas manifesting only with compressive symptoms. Genetic analysis in the father showed no MEN-1 germ-line mutation. Tissue samples obtained after paraseptal trans-sphenoidal surgery were studied by immunohistochemistry for adenohypophyseal hormones, low molecular weight cytokeratins (CAM 5.2), proliferation markers, and anterior pituitary transcription factors (Pit-1 and SF-1) and by electron microscopy for secretory granules. The clinical, histological, and immunohistochemical features of the lesions posed a differential diagnosis between a null cell adenoma and a silent corticotroph adenoma (Type II); on the basis of immunohistochemical stains for cytokeratin and adenohypophysis cell lineage markers, tumor behavior and ultrastructural studies we concluded for the second. The reported cases represent an as yet undescribed example of homogeneous family with silent corticotroph adenomas (Type II). Our observations support the trend for more aggressive behavior in nonsecreting FIPAs as compared with sporadic adenomas.

0 0
 · 
0 Bookmarks
 · 
76 Views
  • [show abstract] [hide abstract]
    ABSTRACT: Pituitary adenomas are benign intracranial neoplasms and clinically apparent pituitary adenomas have a prevalence of approximately 1:1,000 individuals. They usually arise sporadically, but familial pituitary adenomas comprise about 5% of all cases, more than half of which include multiple endocrine neoplasia type 1 (MEN1) and Carney complex (CNC). The other half is represented by familial isolated pituitary adenomas (FIPA), a clinical entity described in the late 1990s. Recently, interest has been focused on the genetic pathophysiology of familial pituitary adenomas. MEN1 is due to mutations in MEN1 gene. CNC is related to PRKAR1A mutations and still unknown disruptions on 2p16. Mutations of CDKN1B in MEN1-like patients without MEN1 mutations allowed the differentiation of the condition as MEN4. About 15% of FIPA kindreds are associated with aryl hydrocarbon receptor-interacting protein (AIP) gene mutations, which suggests that this is a genetically heterogeneous condition. Overall, familial pituitary adenomas represent a small proportion of pituitary tumors, but are particularly significant as affected individuals may be younger, and adenomas may be relatively difficult to treat. KeywordsMultiple endocrine neoplasia type 1-MEN4-Carney complex-Familial isolated pituitary adenomas
    12/2010: pages 137-150;
  • Source
    [show abstract] [hide abstract]
    ABSTRACT: According to data derived from autopsy and radiological imaging series, pituitary tumours occur very commonly in the general population; however, most of these tumours are incidental findings with no obvious clinical impact. The historical data on the prevalence of pituitary adenomas in the clinical setting are scant and point to such tumours being relatively rare. Recent studies have shown that the prevalence of clinically relevant pituitary adenomas is 3-5 times higher than previously reported, which adds impetus to research into the aetiology of these tumours. Although the majority of pituitary adenomas are sporadic, approximately 5% of all cases occur in a familial setting and over half of these are due to Multiple Endocrine Neoplasia Type 1 (MEN-1) and Carney's Complex (CNC) disorders. Since the late 1990 s, we have described non-MEN1/CNC familial pituitary tumours that include all tumour phenotypes as a condition termed Familial Isolated Pituitary Adenomas (FIPAs). The clinical characteristics of the FIPAs vary from those sporadic pituitary adenomas, as patients with FIPAs have a younger age at diagnosis and larger tumours. About 15% of the FIPA patients have mutations in the aryl hydrocarbon receptor-interacting protein gene (AIP), which indicates that the FIPA may have a diverse genetic pathophysiology.
    Best practice & research. Clinical endocrinology & metabolism 10/2009; 23(5):543-54. · 3.89 Impact Factor
  • [show abstract] [hide abstract]
    ABSTRACT: Molecular alterations in endocrine tumors can be related to genetic syndromes or can be somatic mutations that are restricted to tumor tissues. Tumors associated with genetic syndromes have been described for all endocrine organs and include medullary thyroid carcinoma, parathyroid tumors, pituitary adenomas, adrenal cortical tumors, and pheochromocytomas. The endocrine syndromes are discussed in detail, with particular attention to mutational analysis. In terms of somatic mutations, the most advanced understanding is for thyroid and parathyroid lesions, where established markers are making their way slowly into clinical practice. Somatic mutations for endocrine tumors are also discussed, with an emphasis on testing that has clinical diagnostic and therapeutic implications. KeywordsPapillary carcinoma–Follicular carcinoma–Medullary carcinoma–Multiple endocrine neoplasia syndrome–BRAF mutation–RAS mutation–RET/PTC translocation–RET mutation–Parathyroid adenoma–Parathyroid carcinoma–Hyperparathyroidism-jaw tumor syndrome–HRPT2 gene–Pituitary adenoma–Carney complex–McCune-Albright syndrome–Adrenal cortical adenoma–Adrenal cortical carcinoma–Beckwith-Wiedemann syndrome–Li-Fraumeni syndrome–Pheochromocytoma–Von Hippel-Lindau syndrome–Neurofibromatosis–Familial paragangliomatosis syndrome
    03/2010: pages 221-234;

Full-text (2 Sources)

View
3 Downloads
Available from
Dec 30, 2013